Follow the 네이처셀 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 네이처셀 has published 42 insider filings. Market capitalisation: €1,556.1bn. The latest transaction was filed on 27 March 2026 (Purchase). Among the most active insiders: 라정찬. All data is openly available.
42
Insider Decl.
n/a
Thresholds
€1m
14 ops.
Buy Volume
n/a
4 ops.
Sell Volume
30Σ signal
Buys €1mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,549 of 28,928 companies
35.0
score / 100
Value
33
Quality
37
FCF yld-1.1%
Earn yld-0.2%
EV/EBITDA·
ROE·
Gross mgn46%
Net mgn-14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
네이처셀 is a company in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development of cell therapies and biopharmaceutical products.